These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia. Wancata J Int Psychogeriatr; 2004 Mar; 16(1):107-15. PubMed ID: 15191000 [TBL] [Abstract][Full Text] [Related]
83. Comparative effectiveness of antipsychotic drugs. Osser DN; Akhter A Am J Psychiatry; 2003 Mar; 160(3):590; author reply 592-3. PubMed ID: 12611853 [No Abstract] [Full Text] [Related]
84. Neuroleptics for behavioral symptoms of dementia. Reynolds PL; Strayer SM J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345 [No Abstract] [Full Text] [Related]
85. The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable. Gharabawi G; Bossie C; Turkoz I; Kujawa M; Mahmoud R; Simpson G J Nerv Ment Dis; 2007 Dec; 195(12):976-82. PubMed ID: 18091190 [TBL] [Abstract][Full Text] [Related]
86. Amoxapine as an antipsychotic: comparative study versus haloperidol. Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123 [TBL] [Abstract][Full Text] [Related]
87. Benefit-risk analysis for the clinician: 'primum non nocere' revisited--the case for antipsychotics in the treatment of behavioural disturbances in dementia. Naarding P; van Grevenstein M; Beekman AT Int J Geriatr Psychiatry; 2010 May; 25(5):437-40. PubMed ID: 20391588 [TBL] [Abstract][Full Text] [Related]
89. [Therapeutic gap when it comes to behavioral symptoms and psychoses among the elderly]. Nygaard HA Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2515. PubMed ID: 15477898 [No Abstract] [Full Text] [Related]
90. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone. Lai YC; Chiou CC; Chen CH; Huang MC J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693 [No Abstract] [Full Text] [Related]
91. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. Perez V; Cañas F; Tafalla M; Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528 [TBL] [Abstract][Full Text] [Related]
93. The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients. Nerius M; Johnell K; Garcia-Ptacek S; Eriksdotter M; Haenisch B; Doblhammer G J Gerontol A Biol Sci Med Sci; 2018 Sep; 73(10):1396-1402. PubMed ID: 29228107 [TBL] [Abstract][Full Text] [Related]
94. Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism. Smith DA; Beier MT J Am Med Dir Assoc; 2004; 5(2):129-32. PubMed ID: 15008183 [No Abstract] [Full Text] [Related]
96. Risperidone and the treatment of delusions of parasitosis in an elderly patient. Gallucci G; Beard G Psychosomatics; 1995; 36(6):578-80. PubMed ID: 7501790 [No Abstract] [Full Text] [Related]
98. Low dose risperidone in the treatment of schizophrenia-like symptoms in high-risk subjects. Rybakowski JK; Drózdz W; Borkowska A J Clin Psychopharmacol; 2003 Dec; 23(6):674-5. PubMed ID: 14624204 [No Abstract] [Full Text] [Related]
99. [Withdrawal versus continuation of antipsychotic drugs in people with dementia]. Lolk A Ugeskr Laeger; 2014 Jul; 176(31):. PubMed ID: 25292325 [TBL] [Abstract][Full Text] [Related]